News of the superbug threat in today's NY Times. According to this article the only recourse is antibiotics. Conclusion: this company is TOTALLY under the radar. This is our problem and our huge opportunity.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.